Diabetes Research and Clinical Practice
Volume 88, Issue 1 , Pages 29-33 , April 2010

Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes

Received 18 October 2009 ,Revised 7 January 2010 ,Accepted 11 January 2010.

References 

  1. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 2004;89:2548–2556
  2. Fukuhara AM, Matsuda M, Nishizawa K, Segawa M, Tanaka K, Kishimoto Y, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307:426–430
  3. Heidemann C, Sun Q, van Dam RM, Meigs JB, Zhang C, Tworoger SS, et al. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann. Intern. Med. 2008;149(5):307–316
  4. Wannamethee SG, Lowe GDO, Rumley A, Cherry L, Whincup PH, Sattar N. Adipokines and risk of type 2 diabetes in older men. Diabetes Care. 2007;30:1200–1205
  5. Ahima RS, Lazar MA. Adipokines and the peripheral and neural control of energy balance. Mol. Endocrinol. 2008;22:1023–1031
  6. Hivert MF, Sullivan LM, Fox CS, Nathan DM, D’Agostino RB, Wilson WF, et al. Associations of adiponectin, resistin, and tumor necrosis factor-α with insulin resistance. J. Clin. Endocrinol. Metab. 2008;93:3165–3172
  7. Lorenzo M, Fernández-Veledo S, Vila-Bedmar R, Garcia-Guerra L, C. De Alvaro CD, Nieto-Vazquez I. Insulin resistance induced by tumor necrosis factor-α in myocytes and brown adipocyte. J. Anim. Sci. 2008;86:E94–E104
  8. Yang R, Xu A, Pray J, Hu H, Jadhao S, Hansen B, et al. Cloning of omentin, a new adipocytokine from omental fat tissue in humans. Diabetes. 2003;(Suppl. 1):A1
  9. Fu M, Gong DW, Damcott C, Sabra M, Yang RZ, Pollin TI, et al. Systematic analysis of omentin 1 and omentin 2 on 1q23 as candidate genes for type 2 diabetes in the old order amish. Diabetes. 2004;53:A59
  10. St. Jean P, Husueh WC, Mitchell B, Ehm M, Wanger M, Burns D, et al. Association between diabetes, obesity, glucose and insulin levels in the old older amish and SNPs on 1q21–23. Am. J. Hum. Genet. 2000;67:332–337
  11. Xiang K, Wang Y, Zheng T, Jia W, Li J, Chen L, et al. Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21–q23 and chromosome 1q21–q24. Diabetes. 2004;53:228–234
  12. Vionnet N, Hani El H, Dupont S, Gallina S, Francke S, Dotte S, et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21–q24. Am. J. Hum. Genet. 2000;67:1470–1480
  13. de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007;56:1655–1661
  14. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am. J. Physiol. Endocrinol. Metab. 2006;290:E1253–E1261
  15. Tan BK, Adya R, Farhatullah S, Lewandowski KC, Hare PO, Lehnert H, et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome. Diabetes. 2008;57:801–808
  16. World Health Organization, Definition, diagnosis and classification of diabetes mellitus and its complications, Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus, Department of Noncommunicable Disease Surveillance, Geneva, 1999, WHO/NCD/NCS/99.2.
  17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  18. Tan BK, Pua S, Syed F, Lewandowski KC, O’Hare JP, Randeva HS. Decreased plasma omentin-1 levels in type 1 diabetes mellitus. Diabet. Med. 2008;25(10):1254–1255
  19. Wurm S, Neumeier M, Weigert J, Schaffler A, Buechler C. Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults. Cardiovasc. Diabetol. 2007;20:6–7
  20. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2001;280:E745–E751
  21. Schaffler A, Neumeier M, Herfarth H, Furst A, Scholmerich J, Buchler C, et al. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim. Biophys. Acta. 2005;1732:96–102
  22. Pickup JC, Chusney GD, Thomas SM, Burt D. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 2000;67:291–300
  23. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, et al. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 2005;289:86–90
  24. Simons PJ, van den Pangaart PS, Aerts JM, Boon L. Pro-inflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization. J. Endocrinol. 2007;192:289–299
  25. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2003;301:1045–1050
  26. Simons PJ, van den Pangaart PS, van Roomen CP, Aerts JM, Boon L. Cytokine-mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis: evidence that tumor necrosis factor-alpha- and interleukin-1 beta-treated human preadipocytes are potent leptin producers. Cytokine. 2005;32:94–103

PII: S0168-8227(10)00016-1

doi: 10.1016/j.diabres.2010.01.013

Diabetes Research and Clinical Practice
Volume 88, Issue 1 , Pages 29-33 , April 2010